Penn discovers new, rare mechanism for ALL to relapse after CAR T cell therapy
Credit: Penn Medicine PHILADELPHIA - A single leukemia cell, unknowingly engineered with the leukemia-targeting chimeric antigen receptor (CAR) lentivirus and infused back into a patient,...








